"We are committed to Women's Health and are excited to announce the commercial availability of this high-resolution 3D solution which will undoubtedly make a positive impact on Canadian radiologists, technologists and patients alike. With this latest addition to the portfolio, Christie Innomed has raised the bar in the Canadian industry. The breakthrough enhancements in the 3Dimensions system make it the obvious choice for Canadian organizations wanting a more accurate exam while increasing patient comfort" says Martin Roy, President and CEO, Christie Innomed Inc.
Industry's fastest and highest resolution 3D™ images1
The 3Dimensions Mammography System features Clarity HD high-resolution 3DTM imaging which reveals more subtle lesions and fine calcifications than previously possible, helping radiologists pinpoint more invasive cancers early. Clarity HD technology's advanced detector and innovative synthetic 2D algorithm, known as Intelligent 2D™, work together to deliver unprecedented clarity, contrast and detail, without compromising on dose or patient compression time.2,3 Designed to increase diagnostic confidence and achieve more accuracy the first time, Clarity HD reduces recalls by up to 40 percent compared to 2D alone.4,5,6,7
New Standard for Automated Breast Density Assessment
Another feature available with the 3Dimensions system is the QuantraTM Breast Density Assessment Software, which enables standardization in patient protocols, providing normalized breast density assessment. Through a proprietary algorithm powered by machine learning, Quantra software analyzes mammography images for distribution and texture of breast tissue, and categorizes breasts into four density categories, in alignment with the ACR BI-RADS® Atlas 5th Edition.8,9
93% of Women Surveyed Reported Improved Comfort with the New System
Hologic's new SmartCurve™ breast stabilization system is clinically proven to deliver a more comfortable mammogram without compromising image quality, disrupting workflow or impacting dose.10 The SmartCurve system was shown to improve comfort in 93 percent of women surveyed.10 Featuring a curved surface that mirrors the contours of a woman's breast, the system is designed to reduce pinching and allow uniform compression over the entire breast, addressing the primary contributors to breast pain experienced during mammography. The system also features proprietary image processing algorithms that ensure the preservation of image quality and accuracy.
The Clarity HD, Intelligent 2D, Quantra software and the SmartCurve system are available on Hologic's new 3Dimensions™ mammography system as enhancement options to existing Hologic Selenia® Dimensions® systems.
www.christieinnomed.com
About Christie Innomed
Established in 1954, Christie Innomed develops, distributes, integrates and supports innovative medical imaging and health information management solutions improving Canadian healthcare performance.
Christie Innomed is a leading medical imaging distributor with over 200 dedicated specialists servicing over 1500 hospitals and clinics with their 5 offices throughout Canada.
1. Data on file and from public sources, 2017 2. Compared to C-view 3. Compared to 2D alone 4. Zuckerman SP, Conant EF, Keller BM, et al. Implementation of Synthesized Two-dimensional Mammography in a Population-based Digital Breast Tomosynthesis Screening Program. Radiology. 2016 Dec;281(3):730- 736. 5. Skaane P, Bandos A, Eben EB, et al. Two-view digital breast tomosynthesis screening with synthetically reconstructed projection images: comparison with digital breast tomosynthesis with full-field digital mammographic images. Radiology. 2014 Jun;271(3):655-63. 6. Bernardi D, Macaskill P, Pellegrini M, et. al. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study. Lancet Oncol. 2016 Aug;17(8):1105-13. 7. McDonald ES, Oustimov A, Weinstein SP, et al. Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening. JAMA Oncol. 2016 Jun 1;2(6):737-43. 8. FDA 510(k) K163623 9. Understanding Quantra(TM) (Version 2.2) User Manual 10. Smith, A. Improving Patient Comfort in Mammography. Hologic WP-00019 Rev 003 (2017). |
SOURCE Christie Innomed
Michèle Gagnon, Marketing Director, +1 450-472-9121 #2228, [email protected]
Related Links
christieinnomed.com
Share this article